
AIms Innovations is revolutionizing core research processes with its AI-powered platform, designed to accelerate discovery, reduce costs, and enhance inclusivity. The platform integrates intelligent AI and automation to streamline participant-based research, from initial preparation and recruitment to data collection and analysis. Key features include automated IRB and survey preparation, multilingual AI-driven participant recruitment and engagement via RAchel, intelligent data collection, automated analytics, and seamless escalation to human teams. AIms Innovations emphasizes data security with its patent-pending EVX platform, ensuring HIPAA/GDPR compliance and verifiable erasure of transient data. Their business model appears to be SaaS, offering a comprehensive solution for academic, medical, public health, pharma, biotech, corporate, marketing, and Web3 sectors. They boast of reducing study timelines from months to minutes and increasing research output.

AIms Innovations is revolutionizing core research processes with its AI-powered platform, designed to accelerate discovery, reduce costs, and enhance inclusivity. The platform integrates intelligent AI and automation to streamline participant-based research, from initial preparation and recruitment to data collection and analysis. Key features include automated IRB and survey preparation, multilingual AI-driven participant recruitment and engagement via RAchel, intelligent data collection, automated analytics, and seamless escalation to human teams. AIms Innovations emphasizes data security with its patent-pending EVX platform, ensuring HIPAA/GDPR compliance and verifiable erasure of transient data. Their business model appears to be SaaS, offering a comprehensive solution for academic, medical, public health, pharma, biotech, corporate, marketing, and Web3 sectors. They boast of reducing study timelines from months to minutes and increasing research output.
Product: AI-powered end-to-end participant research platform (IRB prep to analysis) with multilingual assistant RAchel
Compliance: Built for audit-ready compliance (HIPAA, GDPR, SOC2, ICH GCP) and data security with patent-pending EVX
Founders: Ryan Warren (Co‑Founder & CEO) and Allison E. Curry, PhD, MPH (Co‑Founder & Chief Scientific Advisor)
Team size: 5 employees
Funding: Grant round closed Jun 3, 2025; total disclosed funding $40,000 (USD)
Participant-based research operations (study design, recruitment, engagement, data collection, and analysis).
2024
Research technology / Health research software
$40,000.00
Most recent disclosed financing reported as a grant round.
“Parallel18 identified as funder for the June 3, 2025 grant round”